Hepalink (Hong Kong) Limited - Net Worth and Insider Trading
Hepalink (Hong Kong) Limited Net Worth
The estimated net worth of Hepalink (Hong Kong) Limited is at least $104 Million dollars as of 2024-12-15. Hepalink (Hong Kong) Limited is the 2201 Interest of corporation controlled by you of HighTide Therapeutics Inc and owns about 108,000,000 shares of HighTide Therapeutics Inc (HKSE:02511) stock worth over $104 Million. Details can be seen in Hepalink (Hong Kong) Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hepalink (Hong Kong) Limited has not made any transactions after 2023-12-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Hepalink (Hong Kong) Limited
Hepalink (Hong Kong) Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hepalink (Hong Kong) Limited owns 1 companies in total, including HighTide Therapeutics Inc (HKSE:02511) .
Click here to see the complete history of Hepalink (Hong Kong) Limited’s form 4 insider trades.
Insider Ownership Summary of Hepalink (Hong Kong) Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02511 | HighTide Therapeutics Inc | 2023-12-22 | 2201 Interest of corporation controlled by you |
Hepalink (Hong Kong) Limited Latest Holdings Summary
Hepalink (Hong Kong) Limited currently owns a total of 1 stock. Hepalink (Hong Kong) Limited owns 108,000,000 shares of HighTide Therapeutics Inc (HKSE:02511) as of December 22, 2023, with a value of $104 Million.
Latest Holdings of Hepalink (Hong Kong) Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02511 | HighTide Therapeutics Inc | 2023-12-22 | 108,000,000 | 0.96 | 103,680,000 |
Holding Weightings of Hepalink (Hong Kong) Limited
Hepalink (Hong Kong) Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Hepalink (Hong Kong) Limited has made a total of 1 transactions in HighTide Therapeutics Inc (HKSE:02511) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in HighTide Therapeutics Inc is the sale of 108,000,000 shares on December 22, 2023, which brought Hepalink (Hong Kong) Limited around $0.
Insider Trading History of Hepalink (Hong Kong) Limited
- 1
Hepalink (Hong Kong) Limited Trading Performance
Hepalink (Hong Kong) Limited Ownership Network
Ownership Network List of Hepalink (Hong Kong) Limited
Ownership Network Relation of Hepalink (Hong Kong) Limited
Hepalink (Hong Kong) Limited Owned Company Details
What does HighTide Therapeutics Inc do?
Who are the key executives at HighTide Therapeutics Inc?
Hepalink (Hong Kong) Limited is the 2201 Interest of corporation controlled by you of HighTide Therapeutics Inc. Other key executives at HighTide Therapeutics Inc include 2202 Interest of your spouse Li Tan , 2501 Other Shenzhen Hepalink Pharmaceutical Group Co., Ltd. , and 2201 Interest of corporation controlled by you Li Li .
HighTide Therapeutics Inc (HKSE:02511) Insider Trades Summary
Over the past 18 months, Hepalink (Hong Kong) Limited made no insider transaction in HighTide Therapeutics Inc (HKSE:02511). Other recent insider transactions involving HighTide Therapeutics Inc (HKSE:02511) include a net sale of 404,500 shares made by Li Li , a net sale of 404,500 shares made by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. , and a net sale of 404,500 shares made by Li Tan .
In summary, during the past 3 months, insiders sold 0 shares of HighTide Therapeutics Inc (HKSE:02511) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,213,500 shares of HighTide Therapeutics Inc (HKSE:02511) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,213,500 shares.
HighTide Therapeutics Inc (HKSE:02511)'s detailed insider trading history can be found in Insider Trading Tracker table.
HighTide Therapeutics Inc Insider Transactions
Hepalink (Hong Kong) Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Hepalink (Hong Kong) Limited. Currently GuruFocus does not have mailing address information for Hepalink (Hong Kong) Limited.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
